USPH 📈 US Physicalrapy - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US90337L1089
USPH: Physical, Therapy, Rehabilitation, Injury, Prevention, Services
U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas. Web URL: https://www.usph.com
Additional Sources for USPH Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
USPH Stock Overview
| Market Cap in USD | 1,491m |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| GiC Sub-Industry | Health Care Facilities |
| IPO / Inception | 1992-05-28 |
USPH Stock Ratings
| Growth 5y | -18.3% |
| Fundamental | 3.40% |
| Dividend | 61.5% |
| Rel. Strength Industry | -65.8 |
| Analysts | 3.83/5 |
| Fair Price Momentum | 83.41 USD |
| Fair Price DCF | 122.67 USD |
USPH Dividends
| Dividend Yield 12m | 1.93% |
| Yield on Cost 5y | 1.64% |
| Annual Growth 5y | 8.57% |
| Payout Consistency | 91.5% |
USPH Growth Ratios
| Growth Correlation 3m | 73.8% |
| Growth Correlation 12m | -45.7% |
| Growth Correlation 5y | -3.6% |
| CAGR 5y | -3.12% |
| CAGR/Mean DD 5y | -0.11 |
| Sharpe Ratio 12m | -0.03 |
| Alpha | -35.32 |
| Beta | 1.36 |
| Volatility | 36.39% |
| Current Volume | 252.7k |
| Average Volume 20d | 113.6k |
What is the price of USPH stocks?
As of December 21, 2024, the stock is trading at USD 91.31 with a total of 252,738 shares traded.
Over the past week, the price has changed by -2.82%, over one month by +0.86%, over three months by +8.04% and over the past year by +0.80%.
As of December 21, 2024, the stock is trading at USD 91.31 with a total of 252,738 shares traded.
Over the past week, the price has changed by -2.82%, over one month by +0.86%, over three months by +8.04% and over the past year by +0.80%.
Is US Physicalrapy a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, US Physicalrapy is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 3.40 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of USPH as of December 2024 is 83.41. This means that USPH is currently overvalued and has a potential downside of -8.65%.
Neither. Based on ValueRay Fundamental Analyses, US Physicalrapy is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 3.40 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of USPH as of December 2024 is 83.41. This means that USPH is currently overvalued and has a potential downside of -8.65%.
Is USPH a buy, sell or hold?
US Physicalrapy has received a consensus analysts rating of 3.83. Therefor, it is recommend to buy USPH.
US Physicalrapy has received a consensus analysts rating of 3.83. Therefor, it is recommend to buy USPH.
- Strong Buy: 1
- Buy: 3
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecast for USPH stock price target?
According to ValueRays Forecast Model, USPH US Physicalrapy will be worth about 92.9 in December 2025. The stock is currently trading at 91.31. This means that the stock has a potential upside of +1.76%.
According to ValueRays Forecast Model, USPH US Physicalrapy will be worth about 92.9 in December 2025. The stock is currently trading at 91.31. This means that the stock has a potential upside of +1.76%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 107.4 | 17.6% |
| Analysts Target Price | 124.8 | 36.6% |
| ValueRay Target Price | 92.9 | 1.8% |